SCHEDULE 13G/A Filed 2026-07-21 Event — SEC 0000906304-26-000104 →

ROYCE & ASSOCIATES LP → Apyx Medical Corporation APYX

Stake: — Shares: — Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 3.88

251,668 shares short · +42.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $78K

Point72 Asset Mgmt

Other Filings by ROYCE & ASSOCIATES LP

Filed	Form	Issuer	Stake	Shares
2026-07-22	SCHEDULE 13G	Westport Fuel Systems Inc.	—	—	view →
2026-07-22	SCHEDULE 13G	Inseego Corp	—	—	view →
2026-07-22	SCHEDULE 13G	LSI Industries Inc.	—	—	view →
2026-07-22	SCHEDULE 13G	OptimizeRx Corp	—	—	view →
2026-07-22	SCHEDULE 13G	Ranger Energy Services, Inc.	—	—	view →
2026-07-21	SCHEDULE 13G	CPI Aerostructures, Inc.	—	—	view →
2018-01-03	SC	LAYNE CHRISTENSEN CO	—	—	view →
2018-01-03	SC	Lipocine Inc. LPCN	—	—	view →
2018-01-03	SC	CSS INDUSTRIES INC	—	—	view →
2018-01-03	SC	AMTECH SYSTEMS INC ASYS	—	—	view →
2018-01-03	SC	SYNALLOY CORP ACNT	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →